ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ADVM Adverum Biotechnologies Inc

10.43
0.43 (4.30%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Adverum Biotechnologies Inc ADVM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.43 4.30% 10.43 23:00:01
Open Price Low Price High Price Close Price Previous Close
10.10 10.00 10.69 10.43 10.00
more quote information »

Recent News

Date Time Source Heading
5/03/202407:00GLOBEAdverum Biotechnologies to Participate in Upcoming May..
4/25/202415:05GLOBEAdverum Biotechnologies to Present LUNA 26-week Phase 2..
3/18/202415:05GLOBEAdverum Biotechnologies Reports Fourth Quarter and Full Year..
3/04/202415:40EDGAR2Form S-3 - Registration statement under Securities Act of..
2/28/202415:05GLOBEAdverum Biotechnologies to Participate in the TD Cowen 44th..
2/22/202414:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202414:39EDGAR2Form D - Notice of Exempt Offering of Securities
2/15/202415:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202419:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202407:00GLOBEAdverum Biotechnologies to Participate in the Oppenheimer..
2/09/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202410:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/08/202407:45EDGAR2Form 8-K - Current report
2/08/202406:00GLOBEAdverum Biotechnologies Announces Positive Preliminary..
2/06/202415:47EDGAR2Form 8-K - Current report
2/05/202416:03EDGAR2Form 8-K - Current report
2/05/202406:45GLOBEAdverum Biotechnologies Announces $127.5 Million Private..
2/01/202416:30GLOBEAdverum Biotechnologies will Host Webcast to Review LUNA..
1/29/202407:00GLOBEAdverum Biotechnologies Appoints Romuald Corbau, Ph.D. as..
12/08/202315:11EDGAR2Form 8-K - Current report
12/07/202315:05GLOBEAdverum Biotechnologies to Present LUNA Preliminary Efficacy..
12/04/202315:09EDGAR2Form 8-K/A - Current report: [Amend]
11/28/202315:05GLOBEAdverum Biotechnologies to Participate in the Evercore ISI..
11/09/202315:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:07EDGAR2Form 8-K - Current report
11/09/202315:05GLOBEAdverum Biotechnologies Reports Third Quarter 2023 Financial..
11/06/202318:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202318:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/06/202315:10EDGAR2Form 8-K - Current report
11/06/202307:00GLOBEAdverum Biotechnologies Appoints C. David Nicholson, Ph.D...
11/04/202316:54GLOBEAdverum Biotechnologies Announces 3-Year Efficacy and Safety..
9/26/202315:05GLOBEAdverum Biotechnologies Announces Positive Aflibercept..
9/21/202315:05GLOBEAdverum Biotechnologies to Participate in Upcoming Investor..
9/18/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202315:05GLOBEAdverum Biotechnologies to Participate in the H.C...
8/21/202315:05GLOBEAdverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as..
8/14/202307:00GLOBEAdverum Biotechnologies to Participate in the H.C...
8/10/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:09EDGAR2Form 8-K - Current report
8/10/202315:05GLOBEAdverum Biotechnologies Completes Enrollment of Phase 2 LUNA..
8/04/202315:18EDGAR2Form 8-K - Current report
7/24/202315:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
6/12/202307:00GLOBEAdverum Biotechnologies Grants License to Ray Therapeutics..
6/02/202307:00GLOBEAdverum Biotechnologies to Participate in the Jefferies..
5/25/202305:30GLOBEAdverum Biotechnologies Announces New Executive Leadership..
5/18/202308:00GLOBEAdverum Biotechnologies Introduces an Intravitreal Gene..

Your Recent History

Delayed Upgrade Clock